ArticleWideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques2025
Outcomes of Nissen sleeve gastrectomy in a short‑term follow‑up: a new future?
Article in Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSleeve gastrectomy (SG) is the most commonly performed bariatric procedure worldwide, offering significant weight loss and remission of obesity-related diseases. However, SG is associated with a high risk of gastroesophageal reflux disease (GERD). To mitigate this issue, a modified procedure combining SG with Nissen fundoplication (Nissen-sleeve gastractomy [NSG]) has been developed.
aimThe primary aim of this study was to assess the effectiveness of NSG in GERD remission. Secondary objectives included the evaluation of short-term weight loss and the resolution of obesity-related diseases. MATERIALS AND
methodsWe conducted s prospective analysis of 34 patients who underwent NSG between September 2023 and August 2024 at a single center in Poland. Inclusion criteria comprised age over 18 years, eligibility for metabolic and bariatric surgery, and GERD symptoms. Data on GERD severity and weight loss outcomes were collected before and after the surgery.
resultsMean (SD) preoperative body mass index was 40.3 (4.4) kg/m². GERD symptom severity decreased from a median score of 8 to 1 (
conclusionsNSG is a safe and effective procedure that leads to GERD remission, while achieving short-term satisfactory weight loss and mitigating obesity-related diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.